You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 20, 2025

Drug Price Trends for NDC 49884-0007


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 49884-0007

Drug NameNDCPrice/Unit ($)UnitDate
ASPIRIN-DIPYRIDAM ER 25-200 MG 49884-0007-02 0.66460 EACH 2024-12-18
ASPIRIN-DIPYRIDAM ER 25-200 MG 49884-0007-02 0.64096 EACH 2024-11-20
ASPIRIN-DIPYRIDAM ER 25-200 MG 49884-0007-02 0.67301 EACH 2024-10-23
ASPIRIN-DIPYRIDAM ER 25-200 MG 49884-0007-02 0.64312 EACH 2024-09-18
ASPIRIN-DIPYRIDAM ER 25-200 MG 49884-0007-02 0.66720 EACH 2024-08-21
ASPIRIN-DIPYRIDAM ER 25-200 MG 49884-0007-02 0.66666 EACH 2024-07-17
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for NDC 49884-0007

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Pharmaceutical Industry: Implications for Drug NDC 49884-0007

Introduction

The pharmaceutical industry is a complex and dynamic sector, influenced by a myriad of factors including regulatory changes, technological advancements, and market trends. This article will delve into the current market analysis and price projections for the pharmaceutical industry, with a focus on the implications for a specific drug identified by its National Drug Code (NDC) 49884-0007.

Understanding the National Drug Code (NDC)

The NDC is a unique, three-segment number that identifies drug products in the United States. It includes the labeler code, product code, and package code, providing a comprehensive identifier for each drug product[5].

Current Market Trends in the Pharmaceutical Industry

Drug Price Inflation

The pharmaceutical industry is expected to experience a moderate level of price inflation in 2025. According to Vizient's summer Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals is projected to be around 3.81%[2]. This inflation is partly driven by the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies.

Impact of Generic and Biosimilar Drugs

The market is also influenced by the increasing competition from generic drugs and biosimilars. Nearly 37% of life sciences executives view competition from these alternatives as a significant trend, which can impact the pricing and market share of branded drugs[3].

Patent Cliff and Mergers and Acquisitions

The biopharma industry is facing a substantial loss of exclusivity due to expiring patents on high-revenue products, with over $300 billion in sales at risk through 2030. This has led to an increased expectation of mergers and acquisitions in 2025, as companies seek to maintain their market positions[3].

Pricing and Access Issues

Pricing and access to drugs remain significant challenges for the life sciences industry. Nearly half of the C-suite executives surveyed by Deloitte expect pricing and access issues to significantly affect their strategies in 2025[3].

Global Pricing Disparities

The United States has notably higher drug prices compared to other regions. According to an ASPE issue brief, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world (excluding the U.S.) in 2022[4].

Digital Transformation and Innovation

The life sciences industry is undergoing significant transformation driven by digital advancements and scientific innovations. The integration of technologies like gen AI and the increased use of data are expected to boost operational efficiencies and drive breakthrough innovations[3].

Implications for Drug NDC 49884-0007

Pricing Projections

Given the overall trend of moderate price inflation, it is likely that the drug identified by NDC 49884-0007 will experience a similar increase in price. However, the exact percentage will depend on various factors such as the drug's category, competition from generics or biosimilars, and any changes in its approved indications.

Market Position

The drug's market position will be influenced by the broader trends in the pharmaceutical industry. If the drug is a branded product facing competition from generics or biosimilars, its market share and pricing could be impacted. Conversely, if it is part of a therapeutic area with expanding indications, such as the GLP-1 market, it may see increased demand and potentially higher prices[3].

Regulatory Compliance

Ensuring compliance with FDA regulations, including the Drug Listing Act, is crucial for maintaining the drug's presence in the market. The drug must be listed in the NDC Directory, which includes prescription drugs, OTC drugs, and insulin products that are commercially distributed[5].

Case Study: Impact of Expanding Indications

The case of semaglutide, a GLP-1 receptor agonist, illustrates how expanding indications can significantly impact drug pricing and market share. Since its approval for additional indications, semaglutide has seen a 77% increase in spend, highlighting the potential for drugs with broad therapeutic applications to drive market growth and higher prices[2].

Key Takeaways

  • Moderate Price Inflation: The pharmaceutical industry is expected to see a moderate level of price inflation in 2025.
  • Competition from Generics and Biosimilars: Increasing competition from generic and biosimilar drugs can impact the pricing and market share of branded drugs.
  • Patent Cliff and M&A: The biopharma industry faces significant patent expirations, leading to increased M&A activities.
  • Global Pricing Disparities: Drug prices in the U.S. are significantly higher than in other regions.
  • Digital Transformation: The industry is undergoing transformation driven by digital advancements and scientific innovations.

FAQs

  1. What is the National Drug Code (NDC) and its significance? The NDC is a unique three-segment number that identifies drug products in the U.S., including the labeler code, product code, and package code. It is crucial for regulatory compliance and market identification[5].

  2. What are the projected price inflation rates for pharmaceuticals in 2025? The overall drug price inflation rate for pharmaceuticals is projected to be around 3.81% in 2025, according to Vizient's summer Pharmacy Market Outlook[2].

  3. How do generic and biosimilar drugs impact the market? Generic and biosimilar drugs increase competition, which can reduce the market share and pricing of branded drugs. Nearly 37% of life sciences executives view this competition as a significant trend[3].

  4. Why are drug prices in the U.S. higher than in other regions? Drug prices in the U.S. are higher due to a combination of factors, including higher prices for the same drugs and a drug mix that skews towards more expensive compounds[4].

  5. What role does digital transformation play in the pharmaceutical industry? Digital transformation, including the use of gen AI and data analytics, is expected to boost operational efficiencies and drive breakthrough innovations in the pharmaceutical industry[3].

Sources

  1. YouTube - NDC Directory https://www.youtube.com/watch?v=uzyYDCSb4fk
  2. Vizient - Pharmacy Market Outlook https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-drug-price-inflation
  3. Deloitte - 2025 Life Sciences Executive Outlook https://www2.deloitte.com/us/en/insights/industry/health-care/life-sciences-and-health-care-industry-outlooks/2025-life-sciences-executive-outlook.html
  4. ASPE - International Market Size and Prices https://aspe.hhs.gov/sites/default/files/documents/4326cc7fe43bc11770598cf2a13f478c/international-market-size-prices.pdf
  5. FDA - National Drug Code Database Background Information https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.